Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7102 USD | +0.32% | +12.36% | -85.52% |
15/03 | Maxim Group Adjusts Quoin Pharmaceuticals Price Target to $4 From $15, Maintains Buy Rating | MT |
14/03 | Quoin Pharmaceuticals Seeks M&A Opportunities | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-85.52% | 2.62M | |
+0.67% | 42.4B | |
+46.79% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |
- Stock Market
- Equities
- QNRX Stock
- News Quoin Pharmaceuticals, Ltd.
- Quoin Pharmaceuticals Signs License Agreement With Genpharm for Genetic Disease Drug Candidate